nach oben

Drugs & Aging

Erschienen in:

01.03.2008 | Current Opinion

Influenza Vaccination and the Elderly

Pandemic Preparedness

verfasst von: Dr Mary Jo Kasten, Gregory A. Poland

Erschienen in: Drugs & Aging | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Seasonal influenza causes significant morbidity and mortality in the elderly, the very young and those with chronic illness, despite the availability of effective vaccines. The mortality and morbidity attributed annually to seasonal influenza are small in comparison to the potential mortality and morbidity of a novel highly pathogenic human influenza A virus strain. The current influenza A/H5N1 virus that has caused epidemics in poultry and is evolving to find new niches needs only to become more efficiently transmitted from human to human to cause the next pandemic. Vaccination is the intervention with the potential to save the most lives when a pandemic occurs. Pandemic awareness and preparedness are essential to decrease the predicted chaos, death and illness arising from the next influenza pandemic.

Fauci AS. Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis 2006; 194Suppl. 2: S73–6PubMedCrossRef

Targonski PV, Poland GA. Seasonal influenza: prevention with influenza vaccines [online]. Available from URL: http://www.medscape.com/viewprogram/6047_pnt [Accessed 2006 Dec 1]

Smith NM, Bresee JS, Shay DK, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55(RR10): 1–42PubMed

Virelizier JL. Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol 1975; 115: 434–9PubMed

Treanor JJ. Influenza virus. In: Mandell GL, Bennett JE, Dolin RD, editors. Principles and practice of infectious diseases. 6th ed. Philadelphia (PA): Churchill Livingstone, 2005: 2060–78

Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull Hist Med 2002; 76: 105–15PubMedCrossRef

Infectious Diseases Society of America (IDSA). Pandemic influenza [online]. Available from URL: http://www.cidrap.umn.edu/idsa/influenza/panflu/biofacts/panflu.html [Accessed 2007 Feb 9]

Reid AH, Taubenberger JK, Fanning TG. The 1918 Spanish influenza: integrating history and biology. Microbes Infect 2001 Jan; 3(1): 81–7PubMedCrossRef

Kobasa D, Takada A, Shinya K, et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004 Oct 7; 431(7009): 703–7PubMedCrossRef

10.

Garcia-Sastre A, Whitley RF. Lessons learned from reconstructing the 1918influenza pandemic. J Infect Dis 2006; 194Suppl. 2: S127–32PubMedCrossRef

11.

Taubenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. Nature 2005 Oct 6; 437(7060): 889–93PubMedCrossRef

12.

Belshe RB. The origins of pandemic influenza: lessons from the 1918 virus. N Engl J Med 2005 Nov 24; 353(21): 2210–1CrossRef

13.

Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996; 18(1): 64–76PubMedCrossRef

14.

US Department of Health and Human Services. Pandemic influenza plan part 1: strategic plan [online]. Available from URL: http://www.hhs.gov/pandemicflu/plan/partl.html [Accessed 2006 Nov 29]

15.

WHO. Avian influenza: assessing the pandemic threat [online]. Available from URL: http://www.who.int/csr/disease/influenza/H5Nl-9reduit.pdf [Accessed 2006 Dec 20]

16.

DHHS PandemicFlu.gov [online]. Available from URL: http://www.pandemicflu.gov [Accessed 2007 Jan 10]

17.

WHO. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. 30 January 2008 [online]. Available from URL: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2008_01_30/en/index.html [Accessed 2008 Jan 30]

18.

Keawcharoen J, Oraveerakul K, Kuiken T, et al. Avian influenza H5N1 in tigers and leopards [online]. Available from URL: http://www.cdc.gov/ncidod/EID/voll0nol2/04-0759.htm [Accessed 2006 Dec 19]

19.

Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza (H5N1). N Engl J Med 2005 Jan 27; 352(4): 323–4CrossRef

20.

Kandun N, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006 Nov 23; 355(21): 2186–94PubMedCrossRef

21.

WHO. Influenza pandemic: phases and strategies [online]. Available from URL: http://www.searo.who.int/LinkFiles/Avian_Flu_Influenza_pandemic_phases_and_strategies.pdf [Accessed 2007 Jun 20]

22.

CDC. Preventing the flu [online]. Available from URL: http://www.cdc.gov/flu/protect/stopgerms.htm [Accessed 2006 Nov 27]

23.

WHO Writing Group. Nonpharmaceutical interventions for pandemic influenza, national and community measures [online]. Available from URL: http://www.cdc.gov/ncidod/EID/vol12no01/05-1371.htm [Accessed 2007 Feb 9]

24.

Vu T, Farish S, Jenkins M, et al. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002; 20: 1831–6PubMedCrossRef

25.

Jefferson T, Rivetti D, Rivetti A, et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005; 366: 1165–74PubMedCrossRef

26.

Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518–27PubMed

27.

Poland GA. If you could halve the mortality rate, would you do it? Clin Infect Dis 2002 Aug 15; 35(4): 378–80PubMedCrossRef

28.

Gurfinkel EP, de la Fuente RL, Mendiz O, et al. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 2002; 105: 2143–7PubMedCrossRef

29.

Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102: 3039–45PubMedCrossRef

30.

Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351: 2611–8PubMedCrossRef

31.

CDC. Self-reported influenza vaccination coverage trends 1989–2005 [online]. Available from URL: http://www.cdc.gov/flu/professionals/vaccination/ [Accessed 2006 Dec 18]

32.

Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomized controlled trial. Lancet 2000; 355: 93–7PubMedCrossRef

33.

Burls A, Jordan R, Barton P, et al. Vaccinating healthcare workers against influenza to protect the vulnerable: is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine 2006; 24(19): 4212–21PubMedCrossRef

34.

Poland GA, Tosh P, Jacobson RM. Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine 2005; 23: 2251–5PubMedCrossRef

35.

Weinstock DM, Eagan J, Malak SA, et al. Control of influenza A on a bone marrow transplant unit. Infect Control Hosp Epidemiol 2000; 21: 730–2PubMedCrossRef

36.

Cunney RJ, Bialachowski A, Thornley D, et al. An outbreak of influenza A in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2000; 21: 449–54PubMedCrossRef

37.

CDC. Interventions to increase influenza vaccination of health care workers: California and Minnesota. MMWR Morb Mortal Wkly Rep 2005 Mar 4; 54(8): 196–9

38.

IDSA. New release: flu experts call for mandatory shots for health care workers [online]. Available from URL: http://www.idsociety.org/Template.cfm?.Section=Home&Template=/ContentManagement/ContentDisplay.cfm&ContentID=17920 [Accessed 2007 Feb 9]

39.

CDC. Advisory Committee on Immunization Practices: Advisory Committee meeting minutes, June 29–30, 2006 [online]. Available from URL: http://www.cdc.gov/nip/ACIP/minutes/acip-min-jun06.txt [Accessed 2006 Dec 19]

40.

Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis 2006; 194Suppl. 2: S111–8PubMedCrossRef

41.

WHO. Responding to the avian influenza pandemic threat [online]. Available from URL: http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_05_8-EN.pdf [Accessed 2007 Feb 9]

42.

Knobler SL, Mack A, Mahmoud A, et al., editors. The threat of pandemic influenza: are we ready? Workshop summary [online]. Available from URL: http://www.nap.edu/execsumm_pdf/11150.pdf [Accessed 2006 Dec 18]

43.

Poland GA. Vaccines against avian influenza: a race against time. N Engl J Med 2006 Mar 30; 354(13): 1411–3PubMedCrossRef

44.

Gerhard W, Mozdzanowska K, Zharikova D. Prospects for universal influenza virus vaccine [online]. Available from URL: http://www.cdc.gov/ncidod/EID/vol12no04/05-1020.htm [Accessed 2007 Feb 10]

45.

Nicholson KG, Colegate AE, Podda A, et al. Safety and antigenicity of non-adjuvanted and MF-50 adjuvanted influenza a/Duck/Singapore/97 (H5N3) vaccine: a randomized trial of two potential vaccines against H5N1 influenza. Lancet 2001; 357: 1937–43PubMedCrossRef

46.

Treanor JJ, Campbell JD, Zangwill KM, et al. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006; 354: 1343–51PubMedCrossRef

47.

Treanor JJ, Betts RF, Smith GE, et al. Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults. J Infect Dis 1996; 173: 1467–70PubMedCrossRef

48.

Treanor JJ, Wilkinson BE, Masseoud F, et al. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 2001; 19: 1732–7PubMedCrossRef

49.

Sambhara S, Poland GA. Avian influenza vaccines: what’s all the flap? Lancet 2006 May 20; 367(9523): 1636–8PubMedCrossRef

50.

Belshe RB, Newman FK, Cannon J, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004; 351: 2286–94PubMedCrossRef

51.

Sambhara S, Bridges CB, Poland GA. H5N1 vaccine hits the target, but not the bull’s eye. Lancet Infect Dis 2007 Aug; 7(8): 503–5PubMedCrossRef

Titel: Influenza Vaccination and the Elderly
Pandemic Preparedness
verfasst von: Dr Mary Jo Kasten
Gregory A. Poland
Publikationsdatum: 01.03.2008
Verlag: Springer International Publishing
Erschienen in: Drugs & Aging / Ausgabe 3/2008
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI: https://doi.org/10.2165/00002512-200825030-00001

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2008

Use of Gabapentin in the Treatment of Behavioural and Psychological Symptoms of Dementia

Association between Visual Acuity and Medical and Non-Medical Costs in Patients with Wet Age-Related Macular Degeneration in France, Germany and Italy

Clinical Features, Differential Diagnosis and Treatment of Autoimmune Hepatitis in the Elderly

Clinical Efficacy of Esomeprazole in the Prevention and Healing of Gastrointestinal Toxicity Associated with NSAIDs in Elderly Patients

Resectable Non-Small Cell Lung Cancer in the Elderly